Stem Cell Anti-Aging: 7 Critical Side Effects and Contraindications You Must Avoid

As interest in stem cells surges, exaggerated claims like "reviving cells" and "stopping aging" are circulating. However, there are critical warning signs you must know before undergoing stem cell procedures. This article presents balanced warnings focusing on side effects actually reported in domestic medical settings including Seoul, contraindicated situations, and 7 representative errors to avoid. General principles and types of stem cells are covered in our basic guide, so this article concentrates solely on "what is dangerous."

Stem cell anti-aging procedures have scientific basis, but they are not safe for everyone. Proceeding indiscriminately while ignoring your health condition, or neglecting complications after they occur can backfire. The following 7 scenarios show clear signals that you "absolutely must not" proceed.

What happens when a patient with active infection undergoes stem cell treatment? When viral or bacterial infection is ongoing, injecting new cells causes the body's immune system to become excessively activated, resulting in explosive increases in inflammatory responses. While stem cells have immune-regulating functions, these are designed to balance normal immune equilibrium, not to suppress active infections.

Real case: A patient in Seoul underwent stem cell procedures while experiencing cold symptoms, and three days later developed high fever and severe swelling at the injection site, requiring antibiotic administration and a 3-week recovery period. While the infection itself did not worsen, inflammation at the procedure site and systemic inflammatory response occurred simultaneously, delaying recovery.

Situations to avoid:

•When experiencing active respiratory infection symptoms such as fever, sore throat, and cough

•When skin wound infection (cellulitis) is ongoing

•When undergoing blood infection (sepsis) treatment

•During acute infection while taking antibiotics

Proper response: Schedule procedures at least 2 weeks after infection has completely resolved, and inform medical staff of any infection history beforehand.

This is the most serious contraindication. While stem cells play positive roles through tissue regeneration and inflammation regulation, paradoxically in a body with cancer cells, they can promote tumor growth. Some stem cells can activate differentiation pathways toward cancer cells in the tumor microenvironment, or can lift suppression of anti-angiogenesis. Additionally, there is risk of promoting neovascularization around tumors, increasing nutrient supply to cancer.

Scientific evidence: The International Stem Cell Society report (2021) classified stem cell procedures in patients with active malignant tumors as "absolutely prohibited." Particularly in patients with blood cancers, lung cancer, and liver cancer, cases of accelerated tumor progression post-procedure have been documented in literature.

Situations to avoid:

•Diagnosed malignant tumors that have not been completely cured

•Currently undergoing cancer treatment

•Cancer remission state but with high recurrence risk (mandatory consultation with medical staff)

•Suspected metastatic disease signals in any body region

Proper response: Only after cancer cure judgment with at least 5 years of no recurrence signs, should procedures be carefully reviewed with dual approval from both oncologists and stem cell specialists.

Patients with autoimmune diseases such as rheumatoid arthritis, lupus, scleroderma, and multiple sclerosis require extreme caution with stem cell procedures. While stem cells regulate immunity, in patients with severe existing autoimmune responses, they can paradoxically further stimulate the immune system. Particularly in progressive autoimmune disease states, new external signals (stem cells) may be mistakenly recognized as antigens attacking one's own body.

Real case: A lupus patient in Seoul underwent mesenchymal stem cell procedures for skin anti-aging purposes. Within two weeks, systemic inflammation markers (CRP, ESR) sharply increased and kidney function declined. Medical staff indicated that the procedure likely triggered existing autoimmune responses.

Situations to avoid:

•Rheumatoid arthritis in active stage (CRP > 10 mg/L)

•Lupus nephritis progression

•Autoimmune disease with high-dose steroid use

•High autoantibody titers in active stage disease

•Autoimmune-related exacerbation episodes within the past 3 months

Proper response: After rheumatologist confirmation of complete clinical remission and normalization of related tests, reassess the situation.

Patients with blood coagulation disorders such as hemophilia, von Willebrand disease, thrombocytopenia, or those taking warfarin and novel oral anticoagulants (DOAC) face risks of injection site bleeding, hematoma formation, and rarely, serious internal bleeding from stem cell procedures. Stem cells are administered by injection, which involves blood vessel puncture, and with reduced clotting function, hemostasis may be delayed or incomplete.

Particularly for patients requiring anticoagulation (atrial fibrillation, thromboembolic history), medication adjustment before and after procedures is essential. Failure to do so simultaneously increases both bleeding and thrombosis risks.

Situations to avoid:

•INR (International Normalized Ratio) > 3.0 state (on warfarin)

•Taking antiplatelet agents (aspirin, clopidogrel) (requires discontinuation 5-7 days before procedure)

•Platelet count < 50,000/μL

•Bleeding episodes within the past month (nosebleeds, gum bleeding, bruising, etc.)

•Deficient clotting factors due to liver cirrhosis

Proper response: If taking anticoagulants, consult with prescribing physician before procedure to establish medication adjustment plan, confirm values through coagulation tests (PT/INR, PTT), then proceed.

With reduced kidney function (GFR < 30 mL/min), bioactive substances such as cytokines and growth factors secreted by injected stem cells may not be sufficiently removed from the body, causing excessive accumulation. Similarly, in cirrhosis or acute liver failure states, metabolism of inflammation-regulating mediators decreases, potentially prolonging systemic inflammation.

Actual report: Some end-stage renal disease (ESRD) patients maintained abnormally elevated blood inflammation markers for extended periods after stem cell procedures, which exacerbated uremic complications.

Situations to avoid:

•Kidney disease stage 4-5 (GFR < 30)

•Currently on dialysis with end-stage kidney disease

•Acute kidney injury (AKI) in progress

•Liver cirrhosis Child-Pugh classification B or higher

•Acute liver failure or active hepatitis

•Creatinine > 3.0 mg/dL

Proper response: Improve kidney and liver function values to near-normal ranges before reassessment, or obtain explicit approval from nephrology and hepatology specialists.

While stem cell procedure safety is becoming established in general adults, clinical data on maternal-fetal transmission risks during pregnancy and breastfeeding remain very limited. The possibility that some stem cell-derived substances cross the placental barrier and newborn exposure through breast milk have not been completely ruled out. Additionally, hormone changes during pregnancy and altered immune regulation may make stem cell responses unpredictable.

Situations to avoid:

•Currently pregnant or planning pregnancy (procedures prohibited at least 3 months before conception)

•Currently breastfeeding (1 month must pass after weaning)

•Undergoing procedures without confirming pregnancy status

•Active uterine-related conditions (endometriosis, uterine fibroids)

Proper response: If planning pregnancy, complete procedures at least 3 months beforehand. If planning to stop breastfeeding, schedule procedures at least 1 month after weaning ends.

Injecting stem cells into patients on long-term steroid therapy or immunosuppressive medications makes it difficult to predict how an already-suppressed immune system will interpret new cell signals. While steroids suppress inflammation, they simultaneously reduce infection defense capabilities, increasing infection risk at procedure sites. Additionally, if existing complications such as steroid-induced diabetes or osteoporosis are present, the tissue regeneration process itself may be impaired.

Real experience: A patient taking prednisolone 30mg/day for autoimmune disease developed fungal skin infection (candidiasis) at the injection site post-procedure, requiring 6 weeks for treatment.

Situations to avoid:

•Long-term use of prednisolone or equivalent > 20mg/day

•Taking immunosuppressants (azathioprine, mycophenolate)

•Receiving biologic agents (TNF-α inhibitors, IL-6 inhibitors)

•Taking post-transplant rejection prevention medications

•History of steroid-induced diabetes or infection

Proper response: Consult with medical staff to reduce steroid dosage as much as possible before considering procedures, while balancing underlying disease management. Generally, proceeding after reducing to minimum 10mg/day or less is standard.

If the following symptoms appear after procedures, immediately contact the procedural medical facility:

Injection site swelling, redness, warmth persisting for 48 hours or longer

High fever (38°C or above) or systemic chills

Pus or abnormal discharge from injection site

Shortness of breath, chest discomfort, heart palpitations

Severe allergic reactions (hives, facial swelling, throat tightness)

Sudden severe joint pain or muscle pain

Skin discoloration, necrosis signs (black or purple changes)

Initial response:

•Immediately visit emergency room or consult medical staff

•Simultaneously report to both the procedural hospital and current primary physician

•Prepare post-procedure progress record, symptom onset time, list of medications taken

•Postpone additional procedures or treatments (reassess after situation stabilization)

Q1. If side effects occur after procedures, how long do they last?

A: Minor side effects (swelling, mild redness) often resolve naturally within 3-7 days. However, infections, serious inflammatory reactions, and allergic symptoms require professional treatment and may persist 2-4 weeks or longer. Serious complications like autoimmune exacerbation or cancer promotion progress over months, making regular testing and monitoring essential.

Q2. I have multiple conditions. Can I still undergo stem cell procedures?

A: It depends on disease type and activity level. Chronic diseases like diabetes and hypertension that are stably managed pose little problem. However, if active infection, malignant tumors, progressive autoimmune disease, and serious kidney-liver failure coexist, procedures should be avoided. You must inform all current primary physicians of stem cell procedure plans and obtain their approval.

Q3. What tests should I undergo first to avoid side effects?

A: At minimum, these tests are essential: (1) Blood tests - infection (WBC, CRP), coagulation (PT/INR, PTT), kidney and liver function (creatinine, liver enzymes), blood glucose (2) Malignant tumor screening - age and gender-specific required cancer screening (3) Autoantibody testing - if autoimmune disease suspected (4) EKG - if 50 years or older or experiencing cardiac symptoms (5) Pregnancy test - for women of reproductive age. Trustworthy medical institutions in Seoul should require all these tests before procedures.

| Health Status | Procedure Possible | Precautions/Alternatives |
|:---|:---|:---|
| Active Infection (pneumonia, sepsis, active TB) | ❌ Absolutely Prohibited | Minimum 2 weeks after cure; completion of antibiotics + return-to-work clearance required |
| Malignant Tumor (diagnosis or treatment) | ❌ Absolutely Prohibited | Cancer cure + 5 years recurrence-free confirmation + oncologist consent mandatory |
| Active Autoimmune Disease (high inflammation state) | ❌ Avoid | Complete remission achievement + antibody level normalization before reassessment |
| Bleeding Disorder/Anticoagulant Use | ⚠️ Conditionally Possible | Medication adjustment required; confirm normal INR range before proceeding |
| Kidney Disease Stage 4-5 | ❌ Avoid | Improvement to GFR > 30 + mandatory nephrologist approval |
| Liver Cirrhosis Stage B or Higher | ❌ Avoid | Improve liver function + hepatologist consent mandatory |
| Pregnancy/Breastfeeding | ❌ Absolutely Prohibited | Completion 3 months before conception or 1 month after weaning |
| High-Dose Steroids (>20mg/day) | ⚠️ Conditionally Possible | Dose reduction (10mg/day or less) + primary physician approval |
| Stable Chronic Disease (diabetes, hypertension) | ✅ Generally Possible | Confirm baseline disease management status; continue regular testing |
| 50+ Years Old, Asymptomatic | ✅ Possible (Conditional) | Baseline tests completed; cancer screening mandatory |

Stem cell anti-aging procedures certainly have scientific basis. However, they are not "cure-all" treatments, nor are they safe for everyone. If any of the 7 contraindications above apply, it is wise to postpone procedures until that situation is completely resolved. Rather than regretting complications after they occur, it is far more efficient to eliminate risks through thorough pre-procedure testing and medical consultation.

Particularly when seeking stem cell-related consultation in Seoul, choose medical institutions that sincerely explain side effect risks, contraindications, and individualized assessment, rather than those emphasizing only anti-aging effects. When you hear clear warnings of "do not proceed" with active infection, malignant tumors, autoimmune disease, coagulation disorders, kidney-liver failure, pregnancy and breastfeeding, or immunosuppressed states, trusting and following that guidance is protecting your life.

If considering stem cell procedures, first accurately assess your current health status, check whether you meet any of the 7 contraindications presented in this article, then consult sufficiently with both your primary physician and the procedural medical staff before deciding.

---

•🌐 Website: https://evarcell.com/

---